Comparing a new asthma medication to an approved one
This study tests a new version of a medication (called QL2302) compared to the approved drug Tezspire®. It aims to see how both are absorbed and processed by the body and to ensure they are safe, in healthy volunteers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old
- Your weight is between 50 and 85 kg (about 110–187 lbs) and your body mass index (BMI) is between 19 and 26
- You are generally healthy, with no major medical conditions
- You have not used certain medications or supplements in the past 2 weeks
- You have no history of allergic reactions to biologic drugs
- You have not received certain vaccines or participated in other drug trials recently
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new inhaler medication to see if it is safe and how the body processes it. It may help in future treatments for lung conditions.
This study tests an experimental medicine (PF-08103402) to see how well it is tolerated and how it acts in the body, in healthy adults and in people with mild-to-moderate asthma. Participation may help researchers learn if this treatment could help manage asthma symptoms.
This study tests a new investigational biologic medicine called QL2302, which is given as an injection, to see if it works as well as a similar approved medicine (Tezspire) for people with severe asthma. If you qualify, you would receive either QL2302 or Tezspire, and the study will track how well your asthma is controlled and your lung function over time.
This trial compares two different forms of an investigational drug to see how they are absorbed into the body. It is for healthy volunteers who want to help researchers understand the safest and most effective way to give the drug.
This study tests a drug called tezepelumab for people with severe asthma that is not well controlled with current treatments. It aims to see if adding this drug can reduce asthma attacks and improve symptoms.
This study tests if tezepelumab can help reduce severe asthma attacks in children ages 5 to 11. It compares the drug to a placebo (a dummy treatment) to see if it is safe and effective.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.